Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2

Ítems similars

• Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
  per: Jiang, Shibo, et al.
  Publicat: (2020)
• A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
  per: Tai, Wanbo, et al.
  Publicat: (2020)
• Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2
  per: Jiang, Shibo, et al.
  Publicat: (2020)
• Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
  per: Du, Lanying, et al.
  Publicat: (2008)
• Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine
  per: He, Yuxian, et al.
  Publicat: (2006)